Peptides for Skin: The Evidence Behind the Big Names

Peptides are the most confidently marketed and least confidently evidenced category in skincare. One peptide has a decent placebo-controlled trial behind it, one has a suggestive trial with a permeation problem, and the most famous one - copper peptide, GHK-Cu - has a reputation its published human evidence does not support. That is not a hit piece. It is what the literature says when you read it.

The four classes of cosmetic peptide

Cosmetic chemistry sorts peptides by what they are proposed to do, not by what they are made of.

Lupo 2007 - Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-9. (opens PubMed in a new tab) put it plainly: “There are three main categories of cosmeceutical peptides: signal peptides, neurotransmitter-affecting peptides and carrier peptides.” A fourth class - enzyme-inhibiting peptides - appears in later reviews. Worth knowing the fourth is a later addition rather than part of the original taxonomy, because marketing copy presents all four as equally settled.

Signal peptides

Proposed to tell fibroblasts to make more matrix. Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923. (opens PubMed in a new tab) lists palmitoyl pentapeptide-4 - Matrixyl - plus PKEK, GEKG and tripeptide-10 citrulline.

Example: Matrixyl (pal-KTTKS). The best-evidenced cosmetic peptide we found. Robinson 2005 - Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60. (opens PubMed in a new tab) ran a 12-week double-blind, placebo-controlled, split-face trial: 93 Caucasian women aged 35–55, pal-KTTKS at 3 parts per million. It “provided significant improvement vs. placebo control for reduction in wrinkles/fine lines by both quantitative technical and expert grader image analysis.” Genuinely good design. The caveat is the author affiliation: The Procter & Gamble Company, Miami Valley Laboratories. Industry authorship does not make a result wrong - it does mean independent replication would be worth more than another company study.

Carrier peptides

Proposed to deliver a trace metal to where enzymes need it. The taxonomy in Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923. (opens PubMed in a new tab) names exactly two - copper tripeptide-1 (Cu-GHK) and manganese tripeptide-1 (Mn-GHK). That is the entire class, and copper peptides get the rest of this page.

Neurotransmitter-inhibiting peptides

Proposed to interfere with muscle contraction at the neuromuscular junction - the “topical Botox” pitch. Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923. (opens PubMed in a new tab) lists acetyl hexapeptide-3 (Argireline), pentapeptide-3 (Vialox), pentapeptide-18 (Leuphasyl) and SNAP-8, noting bluntly of Vialox that “there are no further investigations directly describing or enhancing anti-wrinkle properties.”

Example: Argireline. Wang 2013 - Wang Y, Wang M, Xiao S et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53. (opens PubMed in a new tab) studied 60 Chinese subjects, 3:1 allocation, twice-daily peri-orbital application for 4 weeks, and reported “total anti-wrinkle efficacy…48.9%, compared with 0% in the placebo group,” with reduced roughness (p<0.01).

Then there is delivery. Zdrada-Nowak 2025 - Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025;26(12). (opens PubMed in a new tab), a review that received no external funding, found the permeation literature flatly contradictory - Blanes-Mira and colleagues reported ~30% of an applied 10% formulation penetrating a membrane in 2 hours, while Kraeling and colleagues found only 0.22% penetrated the stratum corneum with none detected in receptor solution at 24 hours. Its conclusion: “the transdermal delivery of AH-8 to induce a paralyzing effect in muscles is likely impossible.”

Enzyme-inhibiting peptides

Badilli 2025 - Badilli U, Inal O. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers (Basel). 2025;17(6). (opens PubMed in a new tab) describes peptides that “directly or indirectly inhibit enzymes, such as MMPs, that contribute to the aging of skin.” Examples: rice-bran peptides (tyrosinase and hyaluronidase inhibition), silk fibroin/sericin (collagen I and III, antityrosinase) and soy oligopeptides (collagen type I gene expression in dermal fibroblasts; reduced UVB erythema).

Note what that evidence is: predominantly in vitro and mechanistic work, in a secondary source. Gene expression in a dish is not a wrinkle.

GHK-Cu: what it is, and where the story came from

GHK is a tripeptide - glycyl-L-histidyl-L-lysine. GHK-Cu is that tripeptide complexed with copper. It is a chelate: the copper is bound, not floating free.

Loren Pickart isolated GHK in 1973, describing it as an activity in human albumin that caused old human liver tissue to synthesize proteins like younger tissue (Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. (opens PubMed in a new tab)) - a genuinely interesting origin, and the start of a fifty-year research thread. Pickart 2008 - Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. (opens PubMed in a new tab) proposes four GHK-Cu mechanisms:

1. Recruitment of repair cells - macrophages and capillary endothelial cells.
2. Anti-inflammatory action, via free-radical suppression and increased antioxidant enzymes.
3. Stimulation of collagen, elastin and growth factor synthesis.
4. Enhanced fibroblast and keratinocyte proliferation.

It is obvious why the internet loves this molecule. But it is the originator’s own framework, not independently replicated consensus - Pickart discovered GHK-Cu and holds commercial interests in it. A mechanism list is a hypothesis about how something might work, not evidence that it does.

The human evidence, honestly

The part that surprised us most - and it is verifiable, not a matter of opinion.

The three studies that anchor most consumer claims are not peer-reviewed journal articles. That is not our reading - it is what the reference list of Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. (opens PubMed in a new tab) says they are. The 71-women facial cream trial is a conference presentation from the American Academy of Dermatology Annual Meeting, February 2002 (Leyden, Stephens, Finkey, Appa, Barkovic). The 41-women eye cream trial is a 2002 University of Pennsylvania report. The 67-women facial study is a 2005 book chapter. Author-field searches return only unrelated records - a basophil histamine study (Dvorak 1995 - Dvorak AM, MacGlashan DW Jr, Morgan ES et al. Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood. 1995;86(9):3560-6. (opens PubMed in a new tab)) and a décolletage photodamage trial (Leyden 2010 - Leyden JJ, Parr L. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin. J Drugs Dermatol. 2010;9(3):220-6. (opens PubMed in a new tab)) - which is consistent with, but not proof of, the AAD data never having been published in full. Posters are not nothing, but they are not peer review, and rarely carry the detail needed to check a result.

The conflict of interest on a widely-cited GHK review. All three authors of Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. (opens PubMed in a new tab) share an affiliation with “Skin Biology, Research & Development Department” in Bellevue, WA - a real commercial manufacturer and retailer of copper peptide cosmetics. The paper states: “The authors declare that there is no conflict of interests regarding the publication of this paper.” We report that as a plain mismatch between the affiliation block and the declaration.

The published RCT is negative. Miller 2006 - Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9. (opens PubMed in a new tab) studied CO2 laser-resurfaced skin over 12 weeks with blinded evaluators and computer image analysis, in 13 completers: “Copper tripeptide complex (GHK-Cu) skin care products placed on CO2 laser-resurfaced skin offered no significant reduction or resolution of posttreatment erythema. Objective evaluation found no significant improvement in wrinkles or overall skin quality.”

Two things matter. Everyone improved - in wrinkles and skin quality - regardless of arm; what was absent was any between-group difference, which is exactly why uncontrolled before-and-after photos are worthless here. And the only endpoint favoring GHK-Cu was the patient-reported questionnaire (P = .04), the endpoint most vulnerable to expectation.

Thirteen people is small, and a negative result in 13 is weak evidence of absence. We are not claiming GHK-Cu was proven not to work; we are claiming this is the published controlled human evidence we could find, and it is one small negative trial. Other GHK-Cu literature exists - in vitro penetration work on human skin (Hostynek 2011 - Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86. (opens PubMed in a new tab)) and reviews (Dou 2020 - Dou Y, Lee A, Zhu L et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. (opens PubMed in a new tab)) - so this is a live research area, not a closed one.

A 2026 meta-analysis does not mention it at all. Nukaly 2026 - Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306. (opens PubMed in a new tab) pooled 19 RCTs and 1,341 participants on peptides for skin aging and included zero GHK-Cu trials. GHK-Cu is not merely absent from the included studies - the string “GHK” and the term “copper tripeptide” do not appear anywhere in the paper’s full text. Copper appears only as a trace cofactor delivered by carrier peptides and as a micronutrient in two oral collagen drinks. So this review is silent on GHK-Cu; it is not evidence against it. The two topical trials it did include used Argireline and alpha-defensin-5/beta-defensin-3; the other 17 were oral collagen peptides or hydrolysates.

That paper also says something about all topical peptides: its topical arm was just two studies, against 17 oral. Peptides overall gave what it calls modest yet statistically significant effects, limited by inadequate blinding and by heterogeneity running from 84% to 99% - high enough that the pooled numbers read as descriptive rather than precise.

Formulation reality: does it even get in?

The question nobody in the category wants to answer - and as far as we can tell, it has never been resolved.

From PubChem (CID 73587), GHK is C14H24N6O4: molecular weight 340.38 Da, computed XLogP −4.4, topological polar surface area 176 Ų, 6 hydrogen-bond donors, 7 acceptors.

Hold that against the rule of thumb everyone quotes. Bos 2000 - Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-9. (opens PubMed in a new tab) proposed that molecules must be under 500 Da to penetrate the corneal layer, resting the case on three lines of evidence: virtually all common contact allergens are under 500 Da, common topical dermatological drugs are under 500 Da, and “all known topical drugs used in transdermal drug-delivery systems are under 500 Dalton.”

At 340 Da, GHK clears that bar. Two caveats follow. Bos and Meinardi wrote an argument paper, not an experimental study - a heuristic, not a measured physical limit, so passing it is permission to be plausible rather than proof of penetration. And molecular weight is only one variable: the stratum corneum is a lipid barrier, and an XLogP of −4.4 with a TPSA of 176 Ų describes an extremely hydrophilic, highly polar molecule. Those properties do not obviously favor crossing a lipid barrier by passive diffusion - but be precise about that sentence’s status. It is an inference from computed descriptors, not a finding: PubChem reports chemistry and says nothing about permeation.

The vitamin C layering question

Where to land: this is internet lore with a plausible chemical rationale and no direct evidence. Separating them AM/PM is a low-cost hedge, not an evidence-based rule. Both of the usual answers are wrong.

“It’s a myth, layer freely” is wrong. PubMed indexes no clinical or in vivo study of GHK-Cu and vitamin C applied topically together - the null holds across several query formulations. But absence of a topical study is not absence of a mechanism. Older laboratory work reported that ascorbate plus a copper-tripeptide complex cleaved DNA and proteins while neither did so alone, and copper-catalyzed ascorbate oxidation is well-documented solution chemistry more broadly. Be clear about the status of both: neither is in our source registry, so we cannot put a checkable reference behind them here, and you should treat them as leads rather than citations. They are also test-tube chemistry, decades old, not a face.

“It’s proven harmful, never combine” is also wrong. Nothing has been shown to happen on skin. We could not find a source measuring what the combination does on skin, in either direction.

Three genuine unknowns sit underneath all of this, and we will not assert either way:

• GHK-Cu is a chelate. The copper is bound, not free, and chelation materially alters redox behavior - so extrapolating free-Cu²⁺ chemistry to a chelate is an inference. We could not find a study measuring this for GHK-Cu specifically. It is the crux of the question, and it appears completely unstudied.
• The pH argument - that L-ascorbic acid at pH ~2.5–3.5 destabilizes the complex and liberates free copper - we found only in brand and blog sources. No primary measurement in a skin context.
• Contact is assumed, not shown. Whether two serums applied minutes apart co-mingle on skin at concentrations where any of this would matter has never been tested.

So if you want to separate them, separate them. It costs nothing but a little routine complexity. Just don’t let anyone tell you - us included - that the science is settled.

Where peptides sit versus retinoids

Not as a substitute. Here is the comparison that matters.

Sitohang 2022 - Sitohang IBS, Makes WI, Sandora N et al. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. Int J Womens Dermatol. 2022;8(1):e003. (opens PubMed in a new tab) systematically reviewed topical tretinoin for photoaging: 7 randomized controlled trials, 739 subjects. “All studies consistently reported that topical tretinoin was efficacious in improving clinical appearance of photoaging in terms of wrinkling, mottled hyperpigmentation, sallowness, and lentigines.” Improvements appeared after 4 months and persisted to 24 months. One honest note: this was a systematic review without meta-analysis, so there is no pooled effect size to quote, and the concentrations it covered ran 0.025%–5%.

Still: tretinoin, 7 RCTs and 739 subjects with consistent findings; GHK-Cu, one small negative RCT. Not a close contest - which is why our position is that peptides are adjuncts. A retinoid is the better-supported place to spend money and skin tolerance; a peptide serum is what you add around it, not instead of it.

What to look for

The useful advice here is short and mostly negative.

• Prefer the peptide with the trial. For a peptide serum with an actual placebo-controlled human study behind it, Matrixyl (palmitoyl pentapeptide-4) is the one. Industry-authored evidence is still evidence.
• Treat copper peptides as an experiment you are running on yourself. If you use them, know that you are outside the published efficacy evidence.
• Ignore the percentage arms race. With no human dose-response data, “7% copper peptide” is a marketing number, not a dosing decision.
• Ignore before-and-after photos. Miller 2006 - Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9. (opens PubMed in a new tab) is the reason: everyone improved in both arms.
• Read the claim language. Under 21 U.S.C. §321 a cosmetic “alters the appearance,” while an article “intended to affect the structure or any function of the body” is a drug. Both turn on intended use - which is why serums talk about the look of fine lines rather than collagen synthesis.
• Sunscreen and a retinoid first. Peptides are the third thing, not the first.

For a walk-through of specific products in this category, see our best peptide serums breakdown.

References

Bibliographic detail is fetched from PubMed, not written by us - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than our judgement.

1. 1.Badilli U, Inal O. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers (Basel). 2025;17(6).ReviewPMID 40292641full text
2. 2.Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-9.ReviewPMID 10839713
3. 3.Dou Y, Lee A, Zhu L et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61.StudyPMID 35083444full text
4. 4.Dvorak AM, MacGlashan DW Jr, Morgan ES et al. Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood. 1995;86(9):3560-6.StudyPMID 7579464
5. 5.Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923.ReviewPMID 33195061full text
6. 6.Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86.StudyPMID 20721598full text
7. 7.Leyden JJ, Parr L. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin. J Drugs Dermatol. 2010;9(3):220-6.Randomised trialPMID 20232582
8. 8.Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-9.ReviewPMID 18045359
9. 9.Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9.Randomised trialPMID 16847171
10. 10.Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306.Systematic reviewPMID 41924746full text
11. 11.Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88.ReviewPMID 18644225
12. 12.Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.ReviewPMID 26236730full text
13. 13.Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60.StudyPMID 18492182
14. 14.Sitohang IBS, Makes WI, Sandora N et al. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. Int J Womens Dermatol. 2022;8(1):e003.ReviewPMID 35620028full text
15. 15.Wang Y, Wang M, Xiao S et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53.Randomised trialPMID 23417317
16. 16.Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025;26(12).ReviewPMID 40565185full text
17. 17.PubChem CID 73587 - GHK computed properties (formula, molecular weight, XLogP, TPSA, H-bond donors and acceptors)- National Center for Biotechnology Informationdatabase
18. 18.21 U.S.C. §321 - Federal Food, Drug, and Cosmetic Act definitions of "cosmetic" (§321(i)) and "drug" (§321(g)(1))- Cornell Law School Legal Information Institutestatute

Keep reading

Related guides

All guides →

• best peptide serumBest Peptide Serum: How to Choose One on EvidenceWhich peptide, at what concentration, in a formula that makes sense, at what price per mL. The criteria that matter when the marketing all sounds identical.9 min readRead guide→
• argirelineArgireline (Acetyl Hexapeptide-8): The Study EvidenceArgireline is sold as a topical Botox alternative. What the randomised cosmetic studies measured, how large the changes were, and where the comparison breaks down.1 min readRead guide→
• matrixylMatrixyl (Palmitoyl Pentapeptide): The EvidenceWhat the cosmetic clinical research on Matrixyl measured, how the trade-name family differs, and why the studies do not transfer to every cream that names it.1 min readRead guide→
• copper peptidesCopper Peptides (GHK-Cu): What the Research ShowsGHK-Cu is the most-hyped cosmetic peptide. What the peer-reviewed work, the conference abstracts and one negative trial add up to, and where the claims outrun them.4 min readRead guide→
• ghk peptideGHK Peptide: GHK vs GHK-Cu ExplainedThe free tripeptide and the copper complex are sold under one name and studied differently. What separates them, and where the marketing overreaches.1 min readRead guide→
• ghk-cu vs matrixylGHK-Cu vs Matrixyl: Two Different Peptide StoriesCopper peptides and Matrixyl-class signal peptides share a shelf and little else. Chemistry, study designs and evidence compared without picking a fake winner.1 min readRead guide→